Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nishio

Showing results (361-370 of 409) with videos related to

Pageof 41
Sort By:
The Journal of Antibiotics|May 1, 1995
Siamycins I and II, new anti-HIV peptides: I. Fermentation, isolation, biological activity and initial characterizationM Tsunakawa, S L Hu, Y Hoshino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancersM Nishio, T Koshikawa, T Kuroishi, et al.
Cellular Immunology|May 1, 1999
Suppression of FRP-1/CD98-mediated multinucleated giant cell and osteoclast formation by an anti-FRP-1/CD98 mAb, HBJ 127, that inhibits c-src expressionM Tajima, S Higuchi, Y Higuchi, et al.
Immunology and Cell Biology|April 2, 1999
Isolation and characterization of monoclonal antibodies directed against murine FRP-1/CD98/4F2 heavy chain: murine FRP-1 is an alloantigen and amino acid change at 129 (P<-->R) is related to the alloantigenicityH Tsumura, M Kawano, M Tajima, et al.
Bone Marrow Transplantation|October 24, 2000
Large scale purification of human blood CD34+ cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheresK Koizumi, M Nishio, T Endo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 11, 2015
Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administrationM Takahata, S Hashino, M Nishio, et al.
Experimental Hematology|July 5, 2001
Stem cell factor protects c-kit+ human primary erythroid cells from apoptosisT Endo, A Odb, I Satoh, et al.
Bone Marrow Transplantation|July 1, 1997
Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitisK Koizumi, K Sawada, M Nishio, et al.
Acta Psychiatrica Scandinavica|November 13, 2010
The effect of Assertive Community Treatment in JapanJ Ito, I Oshima, M Nishio, et al.
Neuroscience|November 21, 2013
The expression of PTEN in the development of mouse cochlear lateral wallY Dong, L Sui, F Yamaguchi, et al.
Pageof 41

Showing results (361-370 of 409) with videos related to

Sort By:
Pageof 41
The Journal of Antibiotics|May 1, 1995
Siamycins I and II, new anti-HIV peptides: I. Fermentation, isolation, biological activity and initial characterizationM Tsunakawa, S L Hu, Y Hoshino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancersM Nishio, T Koshikawa, T Kuroishi, et al.
Cellular Immunology|May 1, 1999
Suppression of FRP-1/CD98-mediated multinucleated giant cell and osteoclast formation by an anti-FRP-1/CD98 mAb, HBJ 127, that inhibits c-src expressionM Tajima, S Higuchi, Y Higuchi, et al.
Immunology and Cell Biology|April 2, 1999
Isolation and characterization of monoclonal antibodies directed against murine FRP-1/CD98/4F2 heavy chain: murine FRP-1 is an alloantigen and amino acid change at 129 (P<-->R) is related to the alloantigenicityH Tsumura, M Kawano, M Tajima, et al.
Bone Marrow Transplantation|October 24, 2000
Large scale purification of human blood CD34+ cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheresK Koizumi, M Nishio, T Endo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 11, 2015
Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administrationM Takahata, S Hashino, M Nishio, et al.
Experimental Hematology|July 5, 2001
Stem cell factor protects c-kit+ human primary erythroid cells from apoptosisT Endo, A Odb, I Satoh, et al.
Bone Marrow Transplantation|July 1, 1997
Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitisK Koizumi, K Sawada, M Nishio, et al.
Acta Psychiatrica Scandinavica|November 13, 2010
The effect of Assertive Community Treatment in JapanJ Ito, I Oshima, M Nishio, et al.
Neuroscience|November 21, 2013
The expression of PTEN in the development of mouse cochlear lateral wallY Dong, L Sui, F Yamaguchi, et al.
Pageof 41